Sclerotherapy for Cystic Hygroma

In a single study, 23 patients underwent sclerotherapy for cystic hyperplasia of the head and neck. The average number of treatments was two, ranging from one to four. In this group, seven patients with macrocystic lesions had a complete clinical response, while four had partial responses. The overall response rate was 73%, with no recurrence. It is a safe procedure, and no complications were reported.

sclerotherapy for cystic hygroma

Cystic hygroma is a benign swelling that is not connected to an organ. The cyst is filled with water. It is a sponge-like mass, with multiple locules filled with lymph fluid. These are deep, while they get smaller near the surface. The sclerotherapy procedure involves injecting a sclerosing solution into the underlying tumor, which destroys the growth and destroys the inflammatory tissue.

Cystic hygromas are rare, benign tumors in the neck that blend in with other critical cervical structures. While surgical management is available, it has risks and may cause morbidity. To date, doxycycline sclerotherapy is a safe and effective treatment option for these tumors. In a recent case study, a 19-month-old patient with a large cystic hygroma was successfully treated.

There are two types of cystic hygromas. One is called a macrocystic and the other is a microcystic. The former is the more common and the more complex type. The latter type is the more challenging and more expensive. The sclerosing-hyperplasia is usually found in children, although the diagnosis is not a common problem for adults.

After macrocystectomy, sclerotherapy is an alternative to surgery for cystic hygroma. The process can be performed at any location on the body. The procedure is a safe and effective option for treating this asymptomatic condition. The treatment is also safe for patients with a history of inflammatory diseases. This can be a good option for those with chronic sclerosing hygroma.

Typically, sclerotherapy for cystic hyperplasia is an alternative to surgery. It can be performed on patients with sclerosing hygroma. It is a very effective alternative for treating this asymptomatic disorder. The doctor must perform a biopsy to properly diagnose and treat the cystic hygroma.

Although the treatment for cystic hygroma is an alternative to surgery, it is not recommended for patients with sclerosing hygroma. The antenatal prognosis for cystic hygroma for a healthy fetus is favorable, but recurrence rates for teratoma in fetuses with enlarged lymphagogue are high.

Cystic hygromas are benign. They rarely require surgery. The best option is to undergo ultrasound imaging. Ultrasounds of the neck may help diagnose these asymptomatic masses. MRI of the lungs is also useful in identifying asymptomatic cystic hygroma. A CT scan can reveal cystic hyperplasia in the second trimester.